ANKLE2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.687800E-01
Normal-vs-Stage2
7.940600E-01
Normal-vs-Stage3
4.505200E-01
Normal-vs-Stage4
7.064000E-01
Stage1-vs-Stage2
7.782600E-01
Stage1-vs-Stage3
5.653600E-01
Stage1-vs-Stage4
3.072600E-01
Stage2-vs-Stage3
4.384600E-01
Stage2-vs-Stage4
3.692200E-01
Stage3-vs-Stage4
2.849600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.552800E-01
Normal-vs-AfricanAmerican
4.778200E-01
Normal-vs-Asian
4.789400E-01
Caucasian-vs-AfricanAmerican
4.148400E-01
Caucasian-vs-Asian
1.805990E-01
AfricanAmerican-vs-Asian
8.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.413200E-01
Normal-vs-Female
7.988400E-01
Male-vs-Female
8.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.957800E-01
Normal-vs-Age(41-60Yrs)
7.644200E-01
Normal-vs-Age(61-80Yrs)
6.070800E-01
Normal-vs-Age(81-100Yrs)
9.531800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.661600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.019000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.493200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.422500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.196800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.314400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.768000E-01
Normal-vs-Daily Drinker
8.116400E-01
Normal-vs-Weekly Drinker
6.739800E-01
Normal-vs-Occasional Drinker
3.961000E-01
Normal-vs-Social Drinker
7.882000E-01
Non Drinker-vs-Daily Drinker
4.129200E-01
Non Drinker-vs-Weekly Drinker
7.500000E-01
Non Drinker-vs-Occasional Drinker
7.119900E-03
Non Drinker-vs-Social Drinker
4.698200E-01
Daily Drinker-vs-Weekly Drinker
6.911200E-01
Daily Drinker-vs-Occasional Drinker
3.391700E-02
Daily Drinker-vs-Social Drinker
9.880000E-01
Weekly Drinker-vs-Occasional Drinker
3.223800E-02
Weekly Drinker-vs-Social Drinker
7.107600E-01
Occasional Drinker-vs-Social Drinker
4.437800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.239600E-01
Normal-vs-Grade 2
8.303800E-02
Normal-vs-Grade 3
8.117800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.882200E-01
Grade 1-vs-Grade 3
1.840000E-01
Grade 1-vs-Grade 4
2.239600E-01
Grade 2-vs-Grade 3
1.268820E-01
Grade 2-vs-Grade 4
8.303800E-02
Grade 3-vs-Grade 4
8.117800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.891800E-01
Normal-vs-NonDiabetic
9.078000E-01
Diabetic-vs-NonDiabetic
1.246840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.366800E-01
Normal-vs-NoPancreatitis
8.025000E-01
Pancreatitis-vs-NoPancreatitis
3.598000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.683000E-01
Normal-vs-N1
8.955000E-01
N0-vs-N1
2.317200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.162600E-01
Normal-vs-TP53-NonMutant
5.047600E-01
TP53-Mutant-vs-TP53-NonMutant
4.022600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
